-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 19, the Jiangsu Provincial Medical Insurance Bureau issued a notice on the "Dual Channel" Management of Drugs in the National Medical Insurance Negotiations and the Handling Procedures for Separate Payment of Drugs (Trial)", which put forward a series of requirements for "dual channel" management and separate payment of drugs
As the "dual channel" policy is rolled out in more places, the out-of-hospital market will usher in greater development potential, and a new round of evolution may take place in the market structure inside and outside the hospital
Medical insurance overall fund payment is settled on a monthly basis
The insured patient shall purchase the medicine at the designated medical institution of the designated national medicine institution with an electronic medical insurance certificate (or a valid ID card, social insurance card) with an electronic or paper prescription issued by the responsible physician
Separate payment policies will be implemented for the 100 drugs included in the "dual channel" management, 83 drugs with long service cycles and high treatment costs and innovative drugs
Combining this list of nationally talked drugs, injections accounted for nearly half, reaching 42 kinds
At the same time, key words such as compiling the total budget of the national medicines, strengthening supervision and inspection, standardizing treatment, and rational use of medicines have appeared frequently
"Dual Channels" Landed to Promote the Speed of Prescription Outflow
As the "dual channel" policy is successively implemented in various places, it is expected that the medical insurance negotiation drugs will achieve rapid increase in volume, and the market structure inside and outside the hospital may change
From the perspective of the industry, the "dual-channel" management model has taken an important step in prescription outflow.
Although "dual-channel" drugs are difficult to directly use as a source of profit, they can be used as a drain to expand revenue
Under the change of channels, the relationship between labor and retail has also changed
Jiangsu Guotan Drug Dual-channel Management and Separate Payment Drug List